Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 15,596,480 10.010% |
1,925,536 (+14.08%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Fresh Del Monte Produce Inc. FDP |
The Vanguard Group | 4,809,451 10.030% |
352,500 (+7.91%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Lennox International Inc. LII |
The Vanguard Group | 3,883,531 10.900% |
680,208 (+21.23%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | BWX Technologies, Inc. BWXT |
The Vanguard Group | 9,211,924 10.070% |
534,706 (+6.16%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | RadNet, Inc. RDNT |
The Vanguard Group | 7,425,218 10.030% |
71,910 (+0.98%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Cytokinetics, Incorporated CYTK |
The Vanguard Group | 11,915,821 10.090% |
154,216 (+1.31%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Kimberly-Clark Corporation KMB |
The Vanguard Group | 35,133,806 10.530% |
4,990,781 (+16.56%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Ford Motor Company F |
The Vanguard Group | 402,083,783 10.300% |
62,185,266 (+18.30%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Valero Energy Corporation VLO |
The Vanguard Group | 34,724,906 10.960% |
2,632,622 (+8.20%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
The Vanguard Group | 16,472,539 10.430% |
2,269,058 (+15.98%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 10,189,953 10.000% |
1,842,504 (+22.07%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Dynatrace, Inc. DT |
The Vanguard Group | 30,161,184 10.100% |
484,877 (+1.63%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | American Healthcare REIT, Inc. AHR |
The Vanguard Group | 15,357,331 10.030% |
7,474,374 (+94.82%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Kadant Inc. KAI |
The Vanguard Group | 1,218,273 10.370% |
243,267 (+24.95%) |
Filing History |
| 2025-01-08 09:54 am Purchase |
2024-12-31 | 13G | Insmed Incorporated INSM |
The Vanguard Group | 18,218,973 10.180% |
4,093,452 (+28.98%) |
Filing History |
| 2025-01-08 09:54 am Purchase |
2024-12-31 | 13G | Humana Inc. HUM |
The Vanguard Group | 12,829,185 10.650% |
1,658,185 (+14.84%) |
Filing History |
| 2025-01-08 09:38 am Purchase |
2024-12-31 | 13G | RXO, Inc. RXO |
The Vanguard Group | 17,203,721 10.690% |
2,009,971 (+13.23%) |
Filing History |
| 2024-12-20 4:58 pm Purchase |
2024-09-30 | 13G | Under Armour, Inc. UA |
The Vanguard Group | 16,575,574 7.770% |
16,575,574 (New Position) |
Filing History |
| 2024-12-20 4:56 pm Purchase |
2024-09-30 | 13G | Bel Fuse Inc. BELFB |
The Vanguard Group | 906,995 8.690% |
906,995 (New Position) |
Filing History |
| 2024-12-20 4:50 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 1,907,640 8.370% |
1,716,876 (+900.00%) |
Filing History |